These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
267 related articles for article (PubMed ID: 15489129)
21. Acute myocardial infarction--coronary thrombosis and salvage of the ischemic myocardium. Maroko PR; Ribeiro LG; Goldberg S Cardiovasc Clin; 1983; 14(1):191-201. PubMed ID: 6137280 [No Abstract] [Full Text] [Related]
22. Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system. Sethi R; Shao Q; Ren B; Saini HK; Takeda N; Dhalla NS Mol Cell Biochem; 2004 Aug; 263(1-2):11-20. PubMed ID: 15524163 [TBL] [Abstract][Full Text] [Related]
23. Calcium as mediator of isoproterenol-induced myocardial necrosis. Bloom S; Davis DL Am J Pathol; 1972 Dec; 69(3):459-70. PubMed ID: 5086900 [TBL] [Abstract][Full Text] [Related]
24. Cardioprotective activity of A.V. Circulo in isoproterenol-induced myocardial necrosis. Chauhan GM; Naik SR J Herb Pharmacother; 2005; 5(4):51-61. PubMed ID: 16635968 [TBL] [Abstract][Full Text] [Related]
25. Plasma cardiac necrosis markers C-troponin I and creatine kinase, associated with increased malondialdehyde levels, induced in rabbits by means of 5-aminolevulinic acid injection. Pinelli A; Trivulzio S; Brenna S; Rossoni G Pharmacology; 2009; 84(5):314-21. PubMed ID: 19844132 [TBL] [Abstract][Full Text] [Related]
26. Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation. Sushama Kumari S; Varghese A; Muraleedharan D; Menon VP Indian J Exp Biol; 1990 May; 28(5):480-5. PubMed ID: 2401523 [TBL] [Abstract][Full Text] [Related]
27. Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Panda VS; Naik SR Exp Toxicol Pathol; 2008 Aug; 60(4-5):397-404. PubMed ID: 18513933 [TBL] [Abstract][Full Text] [Related]
28. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Yogeeta SK; Hanumantra RB; Gnanapragasam A; Senthilkumar S; Subhashini R; Devaki T Basic Clin Pharmacol Toxicol; 2006 May; 98(5):467-72. PubMed ID: 16635105 [TBL] [Abstract][Full Text] [Related]
29. Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats. Rajadurai M; Prince PS Phytother Res; 2009 Mar; 23(3):358-62. PubMed ID: 18844325 [TBL] [Abstract][Full Text] [Related]
30. [Propranolol protects the myocardium and prevents arterial hypotension in an experimental organ donation model]. Ojeda Rivero R; Cerro Sánchez J; Ordóñez Fernández A; Domínguez Roldán JM; Hernández Fernández A Rev Esp Anestesiol Reanim; 2002 May; 49(5):229-37. PubMed ID: 12216505 [TBL] [Abstract][Full Text] [Related]
31. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes. Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882 [TBL] [Abstract][Full Text] [Related]
32. Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats. Buttros JB; Bergamaschi CT; Ribeiro DA; Fracalossi AC; Campos RR Pharmacology; 2009; 84(1):29-37. PubMed ID: 19494560 [TBL] [Abstract][Full Text] [Related]
33. Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats. Sangeetha T; Quine SD J Appl Toxicol; 2008 Jul; 28(5):710-6. PubMed ID: 18172887 [TBL] [Abstract][Full Text] [Related]
34. Influence of timing of troponin elevation on clinical outcomes and use of evidence-based therapies for patients with non-ST-segment elevation acute coronary syndromes. Roe MT; Peterson ED; Pollack CV; Newby LK; Li Y; Christenson RH; Peacock WF; Fesmire FM; Diercks D; Kirk JD; Smith SC; Ohman EM; Gibler WB; Ann Emerg Med; 2005 Apr; 45(4):355-62. PubMed ID: 15795713 [TBL] [Abstract][Full Text] [Related]
35. [The use of labetalol and propranolol in patients who have had a myocardial infarct]. Il'iash MG; Kravtsova LA; Babov KD; Shcherbak IaIu Vrach Delo; 1990 May; (5):26-8. PubMed ID: 2396387 [TBL] [Abstract][Full Text] [Related]